
Daxyclot 2.5mg Tablet
Marketer
Daxia Healthcare
Salt Composition
Rivaroxaban (2.5mg)
Overview Daxyclot 2.5mg Tablet
CardioGuard 2.5mg tablets function as an anticoagulant, effectively preventing and treating blood clots. This medication lowers the risk of stroke and heart attack by inhibiting clot formation in leg, lung, brain, and heart veins. Frequently prescribed for patients with atrial fibrillation to prevent thrombus development, CardioGuard 2.5mg is also used post-knee or hip replacement to minimize clotting risks. It can be taken with or without food, consistently at the same time daily for optimal efficacy. Long-term use, potentially lifelong, may be necessary; never discontinue or adjust dosage without consulting your physician, as this significantly increases the risk of stroke, heart attack, or thrombosis. Lifestyle modifications, including a healthy diet, regular exercise, weight management, and smoking cessation, further reduce clot risk. Increased bleeding susceptibility (e.g., nosebleeds, easy bruising) is a common side effect; report any unusual symptoms promptly. Contraindicated in individuals with severe liver or kidney disease, active bleeding, or concurrent use of other anticoagulants. Breastfeeding is not advised during treatment. Unlike some anticoagulants, routine PT-INR blood monitoring is unnecessary.
Uses of Daxyclot 2.5mg Tablet
Preventing and managing blood clots
Major Benefits of Daxyclot 2.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Daxyclot 2.5mg Tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, although consistent timing is recommended.
Common Side effects of Daxyclot 2.5mg Tablet:
- Bleeding
How to use Daxyclot 2.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the 2.5mg Daxyclot tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or not, though consistent timing is recommended.
How Daxyclot 2.5mg Tablet works:
Factor Xa inhibitor Daxyclot (2.5mg tablets) is a new oral anticoagulant that prevents blood clot formation by blocking the action of factor Xa.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Daxyclot 2.5mg Tablet concurrently with alcohol. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Daxyclot 2.5mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
Employing Daxyclot 2.5mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Daxyclot 2.5mg tablets may induce side effects, including dizziness or fainting, potentially impairing driving ability.
KidneyCAUTION
Patients with impaired kidney function should use Daxyclot 2.5mg tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. Daxyclot 2.5mg tablets are contraindicated in individuals with severe kidney disease.
LiverUNSAFE
Patients with liver impairment should likely refrain from using Daxyclot 2.5mg tablets due to potential safety concerns. A physician's consultation is recommended.
What if you forget to take Daxyclot 2.5mg Tablet :
Should you forget a Daxyclot 2.5mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Daxyclot 2.5mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Morpholine and thiophene derivatives |
| Developing Habits | No. |
| Type of Therapy | KINSHIP |
| Action class | Factor Xa Inhibitors (Oral) |
